Literature DB >> 20818484

Oxidative stress parameters in paediatric non-alcoholic fatty liver disease.

Valerio Nobili1, Maurizio Parola, Anna Alisi, Fabio Marra, Fiorella Piemonte, Christina Mombello, Salvatore Sutti, Davide Povero, Virginia Maina, Erica Novo, Emanuele Albano.   

Abstract

We have investigated the presence and the possible clinical implications of oxidative stress in children with non-alcoholic fatty liver disease (NAFLD). The present study was an observational study of oxidative stress parameters in the progression of paediatric NAFLD. We observed the role of oxidative stress in children diagnosed with NAFLD by evaluating: serum protein carbonyls, hepatic expression of 8-hydroxy-2-deoxyguanosine (8-OHG), and circulating antibody against malondialdehyde adducted human serum albumin (MDA-HSA). Forty consecutive children with biopsy-proven NAFLD (27 male; 13 female) referred to Bambino Gesù Children's Hospital, Rome, Italy, from January 2007 to April 2008 were included in the study. Serum variations of protein carbonyls, 8-OHG, and circulating antibody against MDA-HSA were evaluated. Elevated protein carbonyls were evident in 33 subjects (83%) irrespective of obesity and insulin resistance. Moreover, liver biopsies of NAFLD patients positive for circulating protein carbonyls also showed a significant increase in the nuclear staining for 8-OHG (p=0.006; 95% CI 3.1-17.7). Anti-MDA-HSA IgG above control threshold was detected in 25 (63%) children. Although protein carbonyl levels were unrelated with disease severity, patients with elevated anti-MDA-HSA IgG had scores for lobular inflammation significantly higher (p=0.019) than subjects with antibodies within the control range, while steatosis, hepatocyte ballooning and fibrosis were similar. High anti-MDA-HSA reactivity was also associated with a 13-fold increased risk (OR=12.9; 95= CI 1.5-113.8; p=0.013) of a NAFLD activity score (NAS) >or=5. These results demonstrate that oxidative stress has an high prevalence in children with NAFLD and is associated with an increased severity of steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818484     DOI: 10.3892/ijmm_00000487

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  37 in total

Review 1.  Modern approach to the clinical management of non-alcoholic fatty liver disease.

Authors:  Maria Del Ben; Licia Polimeni; Francesco Baratta; Daniele Pastori; Lorenzo Loffredo; Francesco Angelico
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Unbalanced oxidant-antioxidant status and its effects in pediatric diseases.

Authors:  Valentina Chiavaroli; Cosimo Giannini; Stefania De Marco; Francesco Chiarelli; Angelika Mohn
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

Review 3.  Controversy in the diagnosis of pediatric non-alcoholic fatty liver disease.

Authors:  Pierluigi Marzuillo; Anna Grandone; Laura Perrone; Emanuele Miraglia Del Giudice
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.

Authors:  A Miccheli; G Capuani; F Marini; A Tomassini; G Praticò; S Ceccarelli; D Gnani; G Baviera; A Alisi; L Putignani; V Nobili
Journal:  Int J Obes (Lond)       Date:  2015-03-26       Impact factor: 5.095

5.  Is there a role for adaptive immunity in nonalcoholic steatohepatitis?

Authors:  Salvatore Sutti; Aastha Jindal; Stefania Bruzzì; Irene Locatelli; Cristina Bozzola; Emanuele Albano
Journal:  World J Hepatol       Date:  2015-07-08

6.  Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ronald J Sokol; Kelley E Capocelli; Zhaoxing Pan; Jillian S Sullivan; Kristen Robbins; Ann C Halbower
Journal:  J Pediatr       Date:  2013-12-07       Impact factor: 4.406

7.  Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH).

Authors:  Ulrike Teufel; Teresa Peccerella; Guido Engelmann; Thomas Bruckner; Christa Flechtenmacher; Gunda Millonig; Felix Stickel; Georg F Hoffmann; Peter Schirmacher; Sebastian Mueller; Helmut Bartsch; Helmut K Seitz
Journal:  Hepatobiliary Surg Nutr       Date:  2015-12       Impact factor: 7.293

8.  Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ann Halbower; Zhaoxing Pan; Kristen Robbins; Kelley E Capocelli; Jelena Klawitter; Colin T Shearn; Ronald J Sokol
Journal:  J Hepatol       Date:  2016-08-05       Impact factor: 25.083

Review 9.  Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.

Authors:  Licia Polimeni; Maria Del Ben; Francesco Baratta; Ludovica Perri; Fabiana Albanese; Daniele Pastori; Francesco Violi; Francesco Angelico
Journal:  World J Hepatol       Date:  2015-06-08

10.  Differential carbonylation of proteins in end-stage human fatty and nonfatty NASH.

Authors:  Colin T Shearn; Laura M Saba; James R Roede; David J Orlicky; Alisabeth H Shearn; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2017-10-06       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.